Literature DB >> 29367766

PTEN loss in the fallopian tube induces hyperplasia and ovarian tumor formation.

Angela Russo1, Austin A Czarnecki1, Matthew Dean1, Dimple A Modi1, Daniel D Lantvit1, Laura Hardy1, Seth Baligod1, David A Davis1,2, Jian-Jun Wei3, Joanna E Burdette4.   

Abstract

The signaling events involved in the onset of ovarian cancer from the fallopian tube epithelium (FTE) are crucial for early detection and treatment of the disease, but they remain poorly defined. Conditional homozygous knockout of PTEN mediated by PAX8-cre recombinase was sufficient to drive endometrioid and serous borderline ovarian carcinoma, providing the first model of FTE-derived borderline tumors. In addition, heterozygous PTEN deletion in the FTE resulted in hyperplasia, providing a model to study early events of human ovarian pathogenesis. To uncover the mechanism underlying the invasion of cancerous oviductal cells to the ovary, PTEN-deficient murine oviductal cells were developed and tagged with green fluorescent protein. Loss of PTEN increased cell migration, invasion, and upregulated WNT4, a key regulator of Müllerian duct development during embryogenesis. Further investigation revealed that WNT4 was required for increased migration and colonization of the ovary by PTEN-deficient oviductal cells in a β-catenin independent manner. Human tumor microarrays and ovarian cancer cells lines confirmed WNT4 expression in cancer and its role in migration. Together, these findings provide a novel model to study the mechanism of fallopian tube tumor initiation and invasion to the ovary mediated by loss of PTEN, which may help to define early events of human ovarian carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29367766      PMCID: PMC6472269          DOI: 10.1038/s41388-017-0097-8

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  54 in total

1.  Identification of ovarian cancer-associated proteins in symptomatic women: A novel method for semi-quantitative plasma proteomics.

Authors:  Kristy L Shield-Artin; Mark J Bailey; Karen Oliva; Ana K Liovic; Gillian Barker; Nicole L Dellios; Simone Reisman; Mustafa Ayhan; Gregory E Rice
Journal:  Proteomics Clin Appl       Date:  2012-04       Impact factor: 3.494

2.  High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease.

Authors:  Yali Zhai; Rong Wu; Rork Kuick; Michael S Sessine; Stephanie Schulman; Megan Green; Eric R Fearon; Kathleen R Cho
Journal:  J Pathol       Date:  2017-07-25       Impact factor: 7.996

Review 3.  The functions and regulation of the PTEN tumour suppressor.

Authors:  Min Sup Song; Leonardo Salmena; Pier Paolo Pandolfi
Journal:  Nat Rev Mol Cell Biol       Date:  2012-04-04       Impact factor: 94.444

4.  Genomic complexity and AKT dependence in serous ovarian cancer.

Authors:  Aphrothiti J Hanrahan; Nikolaus Schultz; Maggie L Westfal; Rita A Sakr; Dilip D Giri; Stefano Scarperi; Manickam Janakiraman; Manickam Janikariman; Narciso Olvera; Ellen V Stevens; Qing-Bai She; Carol Aghajanian; Tari A King; Elisa de Stanchina; David R Spriggs; Adriana Heguy; Barry S Taylor; Chris Sander; Neal Rosen; Douglas A Levine; David B Solit
Journal:  Cancer Discov       Date:  2012-01       Impact factor: 39.397

5.  Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion.

Authors:  Anil K Sood; Jeremy E Coffin; Galen B Schneider; Mavis S Fletcher; Barry R DeYoung; Lynn M Gruman; David M Gershenson; Michael D Schaller; Mary J C Hendrix
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

6.  Tumorigenesis and peritoneal colonization from fallopian tube epithelium.

Authors:  Sharon L Eddie; Suzanne M Quartuccio; Eoghainin Ó hAinmhir; Georgette Moyle-Heyrman; Dan D Lantvit; Jian-Jun Wei; Barbara C Vanderhyden; Joanna E Burdette
Journal:  Oncotarget       Date:  2015-08-21

7.  Combined image and genomic analysis of high-grade serous ovarian cancer reveals PTEN loss as a common driver event and prognostic classifier.

Authors:  Filipe C Martins; Ines de Santiago; Anne Trinh; Jian Xian; Anne Guo; Karen Sayal; Mercedes Jimenez-Linan; Suha Deen; Kristy Driver; Marie Mack; Jennifer Aslop; Paul D Pharoah; Florian Markowetz; James D Brenton
Journal:  Genome Biol       Date:  2014-12-17       Impact factor: 13.583

8.  Ovulation and extra-ovarian origin of ovarian cancer.

Authors:  Yang Yang-Hartwich; Marta Gurrea-Soteras; Natalia Sumi; Won Duk Joo; Jennie C Holmberg; Vinicius Craveiro; Ayesha B Alvero; Gil Mor
Journal:  Sci Rep       Date:  2014-08-19       Impact factor: 4.379

9.  Xwnt11 is a target of Xenopus Brachyury: regulation of gastrulation movements via Dishevelled, but not through the canonical Wnt pathway.

Authors:  M Tada; J C Smith
Journal:  Development       Date:  2000-05       Impact factor: 6.868

10.  Cadherin-6 type 2, K-cadherin (CDH6) is regulated by mutant p53 in the fallopian tube but is not expressed in the ovarian surface.

Authors:  Subbulakshmi Karthikeyan; Daniel D Lantvit; Dam Hee Chae; Joanna E Burdette
Journal:  Oncotarget       Date:  2016-10-25
View more
  32 in total

1.  Inactivation of TRP53, PTEN, RB1, and/or CDH1 in the ovarian surface epithelium induces ovarian cancer transformation and metastasis.

Authors:  Mingxin Shi; Allison E Whorton; Nikola Sekulovski; Marilène Paquet; James A MacLean; Yurong Song; Terry Van Dyke; Kanako Hayashi
Journal:  Biol Reprod       Date:  2020-04-24       Impact factor: 4.285

2.  Exposure of the extracellular matrix and colonization of the ovary in metastasis of fallopian-tube-derived cancer.

Authors:  Matthew Dean; Vivian Jin; Angela Russo; Daniel D Lantvit; Joanna E Burdette
Journal:  Carcinogenesis       Date:  2019-03-12       Impact factor: 4.944

3.  Detection of Ovarian Cancer Using Samples Sourced from the Vaginal Microenvironment.

Authors:  Melissa M Galey; Alexandria N Young; Valentina Z Petukhova; Mingxun Wang; Jian Wang; Amrita Salvi; Angela Russo; Joanna E Burdette; Laura M Sanchez
Journal:  J Proteome Res       Date:  2019-12-02       Impact factor: 4.466

4.  Reduced PAX2 expression in murine fallopian tube cells enhances estrogen receptor signaling.

Authors:  Jose A Colina; Peter Varughese; Subbulakshmi Karthikeyan; Amrita Salvi; Dimple A Modi; Joanna E Burdette
Journal:  Carcinogenesis       Date:  2020-07-10       Impact factor: 4.944

Review 5.  The biochemical and clinical implications of phosphatase and tensin homolog deleted on chromosome ten in different cancers.

Authors:  Qinyi Wang; Junmin Wang; Hongjiao Xiang; Peilun Ding; Tao Wu; Guang Ji
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

6.  Ex Vivo Ovarian Culture to Model the Initial Metastasis in Ovarian Cancer.

Authors:  Matthew Dean
Journal:  Methods Mol Biol       Date:  2022

7.  Tolfenamic acid inhibits ROS-generating oxidase Nox1-regulated p53 activity in intrastriatal injection of malonic acid rats.

Authors:  Xin Yang; Heling Zhang; Tong Qu; Yi Wang; Yongxian Zhong; Yuchen Yan; Xuefei Ji; Tiayan Chi; Peng Liu; Libo Zou
Journal:  J Physiol Sci       Date:  2022-07-18       Impact factor: 2.257

Review 8.  Fallopian tube initiation of high grade serous ovarian cancer and ovarian metastasis: Mechanisms and therapeutic implications.

Authors:  Tova M Bergsten; Joanna E Burdette; Matthew Dean
Journal:  Cancer Lett       Date:  2020-02-15       Impact factor: 8.679

9.  Exposure of human fallopian tube epithelium to elevated testosterone results in alteration of cilia gene expression and beating.

Authors:  Tia Jackson-Bey; José Colina; Brett C Isenberg; Jonathan Coppeta; Margrit Urbanek; J Julie Kim; Teresa K Woodruff; Joanna E Burdette; Angela Russo
Journal:  Hum Reprod       Date:  2020-09-01       Impact factor: 6.918

Review 10.  WNT4 Balances Development vs Disease in Gynecologic Tissues and Women's Health.

Authors:  Lauren M Pitzer; Marisa R Moroney; Natalie J Nokoff; Matthew J Sikora
Journal:  Endocrinology       Date:  2021-07-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.